The same group identified the Kras/YY1/ZNF322A/Shh transcriptional axis as part of an important mechanism underlying neo-angiogenesis and migration of lung cancer cells in in vitro/vivo models [60]. This evidence concerns the gene KRAS and lung carcinoma.